van der Poel HG - Search Results

1

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, Henry AM, van der Kwast TH, Lam TB, Lardas M, Liew M, Mason MD, Moris L, Oprea-Lager DE, van der Poel HG, Rouvière O, Schoots IG, Tilki D, Wiegel T, Willemse PM, Cornford P. Mottet N, et al. Among authors: van den bergh rcn, van den broeck t, van der kwast th, van der poel hg. Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7. Eur Urol. 2021. PMID: 33172724

2

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

3

Clinical experience in Europe with uroselective alpha1-antagonists.

Debruyne FM, Van der Poel HG. Debruyne FM, et al. Among authors: van der poel hg. Eur Urol. 1999;36 Suppl 1:54-8; discussion 65. doi: 10.1159/000052319. Eur Urol. 1999. PMID: 10393474 Review.

4

Gender differences in stage distribution of bladder cancer.

Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA. Mungan NA, et al. Among authors: van dijck ja, van der poel hg. Urology. 2000 Mar;55(3):368-71. doi: 10.1016/s0090-4295(99)00481-1. Urology. 2000. PMID: 10699612

5

Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.

Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H, de la Rosette JJ. Sedelaar JP, et al. Among authors: van leenders gj, van der laak ja, van der poel hg. Eur Urol. 2001 Sep;40(3):285-93. doi: 10.1159/000049788. Eur Urol. 2001. PMID: 11684844

6

Smart drugs in prostate cancer.

van der Poel HG. van der Poel HG. Eur Urol. 2004 Jan;45(1):1-17. doi: 10.1016/j.eururo.2003.08.011. Eur Urol. 2004. PMID: 14667509 Review.

7

Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.

van der Poel HG. van der Poel HG. J Urol. 2004 Oct;172(4 Pt 1):1333-7. doi: 10.1097/01.ju.0000138829.97838.19. J Urol. 2004. PMID: 15371835

8

Perineal salvage prostatectomy for radiation resistant prostate cancer.

van der Poel HG, Beetsma DB, van Boven H, Horenblas S. van der Poel HG, et al. Among authors: van boven h. Eur Urol. 2007 Jun;51(6):1565-71; discussion 1572. doi: 10.1016/j.eururo.2006.08.011. Epub 2006 Aug 24. Eur Urol. 2007. PMID: 16949728

9

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH. van den Bergh RC, et al. Among authors: van der hoeven j, van der poel hg. BJU Int. 2010 Apr;105(7):956-62. doi: 10.1111/j.1464-410X.2009.08887.x. Epub 2009 Oct 8. BJU Int. 2010. PMID: 19817747

10

Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications.

Murphy DG, Bjartell A, Ficarra V, Graefen M, Haese A, Montironi R, Montorsi F, Moul JW, Novara G, Sauter G, Sulser T, van der Poel H. Murphy DG, et al. Eur Urol. 2010 May;57(5):735-46. doi: 10.1016/j.eururo.2009.12.021. Epub 2009 Dec 28. Eur Urol. 2010. PMID: 20036784 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page